Stem cell talk
02 February 2006
ATTENTION: Political, science and medical writers and editors
Kathleen Maclay, Media Relations
"A Conversation with Robert Klein," chair of the independent citizens' oversight committee for the California Institute for Regenerative Medicine, a state agency overseeing the use of public funds for stem cell research.
The conversation at the University of California, Berkeley, is the Goldman School of Public Policy's 2006 Rhoda Goldman Distinguished Lecture in Health Policy.
7:30-9 p.m., Wednesday, Feb. 8
Chevron Auditorium, International House, 2299 Piedmont Ave., at the intersection of Piedmont and Bancroft Way. For a map, see http://www.berkeley.edu/map/.
Klein was a primary backer of Proposition 71, a 2004 ballot initiative that resulted in the creation of the California Institute for Regenerative Medicine. The institute's board is expected to vote on Friday, Feb. 10, on intellectual property rules and, later in the month, on medical, ethical and scientific standards. Klein's son was diagnosed with juvenile diabetes in 2001, and his mother was diagnosed with Alzheimer's disease a year later. He is a strong advocate for research and development of cures for such diseases. Time magazine named him one of the 100 most influential people of the year in 2005.